Skip to content

Follow up study of cruciate ligament reconstruction augmented with internal brace and Mesh

ACL/PCL reconstruction augmented with internal brace - Follow-up study of cruciate ligament reconstruction with new internal brace and Mesh

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059696
Enrollment
Unknown
Registered
2022-05-08
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

posterior cruciate ligament injury

Interventions

internal brace :internal brace augmentation
transtibial group without internal brace:transtibial

Sponsors

First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Fracture of posterior cruciate ligament; 2. Agree to accept the operation of reconstruction of posterior cruciate ligament of knee joint (internal brace, mesh, suture tape reinforcement); 3. Between 18 and 50 years old, male or female; 4. Willing to participate in this prospective study; 5. No surgical contraindication.

Exclusion criteria

Exclusion criteria: 1.Known osseous fractures that could impair revalidation and/or ACL repair; 2.Patients with neurological disorders or systemic diseases; 3.Patients with trauma/fractures in the lower limb in the past 6 months that could influence rehabilitation; 4.Non-sportive patients with a Tegner score of <3: these patients could probably counteract instability complaints with intensive physiotherapy; 5. Any inflammatory disease, Rheumatoid Arthritis (RA), Spondyloarthropathy (SpA), active malignancy; 6. Patient not suited for intervention due to lack of mobility, meaning not achieving 90° of flexion before surgery.

Design outcomes

Primary

MeasureTime frame
IKDC;Lyshlom;

Countries

china

Contacts

Public ContactHangzhou Zhang

First Affiliated Hospital of China Medical University,

zhanghz1000@sina.com+86 15304000715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026